Dr. Kam W. Leong is the Samuel Y. Sheng Professor of Biomedical Engineering and Systems Biology at Columbia University. He moved to Columbia University in 2014, focusing on research directions of nonviral gene editing, oral delivery of biologics, biomaterials-mediated inflammation modulation, and iPSC-based tissue-on-a-chip. He has published ~400 peer-reviewed research manuscripts with citations exceeding 52,000 and an h-index of 120, and holds more than 60 issued patents. His work has been recognized by the Society for Biomaterials Clemson Award and the CAB Global Biomaterials Leadership Award. His work has also been recognized by the 2025 IEEE Biomedical Engineering Award, for pioneering contributions to bionanotechnology that transformed therapies with drug and gene delivery, gene editing, and anti-inflammation nanomaterials. He is the Editor-in-Chief of Biomaterials, and a member of the USA National Academy of Inventors, National Academy of Engineering, and National Academy of Medicine.